Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I just wrote the following message for someone who asked me why Anavex's drugs would work if Alzheimer's was caused by EMF. Personally I don't believe that "Alzheimer's" exists as a single disease. It was a catch all term to cover the fact that the medical profession didn't understand what was going on.
This was my response to that question:
If you believe that I'd like to tell you about this bridge I have for sale...
Powell and crew intend to slow the economy a bit. The Fed is always seeking a healthy homeostasis in the economy.
What if there are multiple Bots controlled by big playas and they are programmed to work together to create an illusion, all smoke and mirrors?
These volume stats are crazy...
05/15/24 0.00 0.00 0.00 0.00 0
05/14/24 0.0384 0.063 0.033 0.055 157,355,686
05/13/24 0.0405 0.0417 0.0367 0.0388 14,771,730
05/10/24 0.0455 0.0463 0.037 0.0399 21,155,977
05/09/24 0.045 0.0455 0.0425 0.0437 10,666,869
05/08/24 0.0448 0.0477 0.0428 0.0444 11,721,048
05/07/24 0.0407 0.046 0.0406 0.0447 11,800,865
05/06/24 0.046 0.047 0.0407 0.042 10,820,532
05/03/24 0.0476 0.0478 0.044 0.0469 10,516,925
05/02/24 0.048 0.0499 0.04 0.0471 17,353,272
05/01/24 0.0444 0.047 0.04 0.0467 20,344,466
04/30/24 0.0502 0.0515 0.045 0.0454 30,517,084
04/29/24 0.0498 0.06 0.046 0.0545 174,364,742
04/26/24 0.0362 0.042 0.035 0.0404 24,576,093
04/25/24 0.0377 0.0378 0.036 0.0366 16,430,417
04/24/24 0.0389 0.0432 0.0376 0.0387 45,739,039
04/23/24 0.035 0.0396 0.034 0.0358 34,789,410
04/22/24 0.04 0.042 0.037 0.038 44,818,033
04/19/24 0.04 0.0466 0.034 0.0418 109,938,395
04/18/24 0.06 0.0683 0.0382 0.04 438,981,416
04/17/24 0.025 0.0468 0.0233 0.0373 490,259,190
04/16/24 0.022 0.024 0.0207 0.0229 20,402,360
04/15/24 0.0238 0.0238 0.0206 0.0219 22,541,021
04/12/24 0.0249 0.0249 0.0232 0.0237 23,713,353
04/11/24 0.025 0.025 0.024 0.0249 13,803,231
04/10/24 0.024 0.025 0.023 0.0248 18,399,623
04/09/24 0.0248 0.0265 0.0237 0.0255 25,558,377
04/08/24 0.0245 0.0259 0.023 0.0248 24,991,434
04/05/24 0.0247 0.0249 0.0223 0.0245 29,964,226
04/04/24 0.026 0.0276 0.024 0.0251 60,472,471
04/03/24 0.0222 0.0245 0.0217 0.023 86,823,549
04/02/24 0.0383 0.0422 0.0335 0.0409 11,433,299
04/01/24 0.043 0.0437 0.0382 0.0388 18,576,438
03/28/24 0.0516 0.0516 0.0483 0.0495 8,563,185
03/27/24 0.05 0.052 0.0485 0.0505 10,735,914
03/26/24 0.0486 0.0539 0.0483 0.0492 16,858,016
03/25/24 0.0447 0.0508 0.0434 0.05 52,687,780
03/22/24 0.094 0.10 0.09 0.0925 7,033,183
03/21/24 0.143 0.1481 0.135 0.136 757,145
03/20/24 0.13 0.143 0.1298 0.1411 2,033,374
03/19/24 0.129 0.134 0.1256 0.13 298,280
03/18/24 0.129 0.1339 0.1216 0.1273 378,018
03/15/24 0.129 0.1294 0.1237 0.125 392,415
03/14/24 0.1238 0.13 0.1215 0.1265 319,146
03/13/24 0.127 0.1307 0.1221 0.128 363,407
03/12/24 0.128 0.1299 0.1159 0.1258 1,204,023
03/11/24 0.134 0.134 0.126 0.1276 809,101
03/08/24 0.1317 0.1332 0.1276 0.132 632,313
03/07/24 0.134 0.1344 0.1277 0.1323 1,188,788
03/06/24 0.1314 0.1369 0.1289 0.13 1,012,317
03/05/24 0.1355 0.1384 0.1305 0.1306 1,668,149
03/04/24 0.14 0.14 0.135 0.1356 767,784
03/01/24 0.1383 0.1398 0.1338 0.1393 419,615
02/29/24 0.137 0.1399 0.136 0.1377 763,227
02/28/24 0.144 0.144 0.133 0.1372 965,174
02/27/24 0.14 0.1456 0.134 0.1428 1,281,051
02/26/24 0.1414 0.145 0.1314 0.1369 2,369,334
02/23/24 0.1446 0.1446 0.1365 0.1412 1,088,516
02/22/24 0.147 0.1489 0.1361 0.14 3,550,616
02/21/24 0.1511 0.2298 0.142 0.1495 25,281,639
02/20/24 0.15 0.15 0.139 0.1477 836,904
02/16/24 0.137 0.15 0.137 0.1446 1,285,065
02/15/24 0.14 0.16 0.133 0.1457 5,331,901
02/14/24 0.1518 0.1534 0.1344 0.1344 1,336,801
02/13/24 0.15 0.1573 0.1445 0.1446 1,593,302
02/12/24 0.1497 0.159 0.1451 0.1504 1,800,554
02/09/24 0.1488 0.1505 0.143 0.1465 2,033,531
02/08/24 0.1339 0.1699 0.131 0.1601 5,611,291
02/07/24 0.1415 0.1415 0.1302 0.1366 2,014,616
02/06/24 0.14 0.1446 0.1371 0.1424 1,751,642
02/05/24 0.151 0.1538 0.1416 0.1485 2,775,575
02/02/24 0.153 0.1629 0.149 0.1553 3,426,072
02/01/24 0.1444 0.1611 0.1403 0.15 4,732,279
01/31/24 0.2444 0.2769 0.15 0.154 37,392,132
01/30/24 0.267 0.272 0.23 0.2351 9,097,256
01/29/24 0.29 0.29 0.2701 0.2724 318,810
01/26/24 0.306 0.306 0.2851 0.2998 61,547
01/25/24 0.2983 0.2983 0.279 0.2888 194,764
01/24/24 0.32 0.325 0.3107 0.3129 58,093
01/23/24 0.32 0.32 0.301 0.3125 52,337
01/22/24 0.292 0.3199 0.292 0.31 83,862
01/19/24 0.296 0.3075 0.295 0.2959 60,272
01/18/24 0.30 0.3098 0.298 0.298 91,723
01/17/24 0.3159 0.3224 0.2881 0.2986 422,161
01/16/24 0.343 0.343 0.322 0.33 464,122
01/12/24 0.37 0.388 0.35 0.359 273,984
01/11/24 0.391 0.3919 0.37 0.3812 187,302
01/10/24 0.40 0.407 0.3601 0.3919 507,927
01/09/24 0.3925 0.3993 0.3821 0.385 266,540
01/08/24 0.39 0.402 0.3893 0.392 457,073
01/05/24 0.414 0.426 0.382 0.4072 4,305,098
01/04/24 0.3901 0.4098 0.39 0.4094 378,908
01/03/24 0.39 0.41 0.39 0.3961 232,840
01/02/24 0.386 0.4001 0.38 0.387 357,179
I was wondering if a the plan is to raise the price so the R/S to retain NASDAQ listing will be smaller...???
Also it's possible that there was significant accumulation at .15 by the powers that be and perhaps they don't want to take a loss on that position.
Honestly, I believe that AI has gotten so strong that they can pretty well call the shots and retail just goes along for the ride.
The whole enchilada - premarket and post market, five minute chart.
I believe that the moves indicated by the pink arrows show that the entire day was under AI control. The buying was real, but there were shakedowns intended to scare folks who bought high.
30 minute chart - note the premarket churn, volume was similar to the previous day. Gap up and early trading attracted attention. I believe it was mostly AI participants playing footsie at first.
LOL!!!! I'm up 291% today on my only penny.....
It's about the tech and quality of management, or in the case of DFCO the lack of same, not the OTC.
What do you expect from a stock with BRIAN BONAR'S track record?
He's been ripping off stockholders since the '80's.
Well, I just derisked my position and I have a 10x return on the remainder.
Very strange....
Seems like an AI manipulation technique to me...
Does anyone really think it's ethical for the CEO of a "public" company (even if it is an OTC penny) to buy out a private company that his family owns? They profit by the buy out that is 100% financed on the OTC.
Totally shady, IMO.
See replied to post for a sample of BONAR's MOA.....
Genific gibberish...
The truth is they have one pharmacy and no unique business plan.
Conclusion
As technology and health advancements continue to evolve, local pharmacies are emerging as vital hubs for providing personalized healthcare services to their communities. This transformation enhances patient outcomes and strengthens the pharmacist-patient relationship, ensuring that each individual receives the care and attention they deserve.
Personalized healthcare is no longer a distant dream; it’s a reality that is unfolding in local pharmacies worldwide. Through integrating technology, implementing health advancements, and committing to patient-centric care, local pharmacies are becoming beacons of personalized healthcare, empowering individuals to take charge of their well-being like never before.
Overview.
Genefic is a wholly-owned subsidiary of Dalrada Financial Corporation (OTCQB: DFCO).
For years, Genefic has focused on building end-to-end, comprehensive health solutions. We understand that a person’s health is not a singular issue or event, nor is it confined to just one aspect.
The company believes in providing total health care solutions for improved health and wellness, including specialty pharmacy services that promote healing, recovery, and an overall better quality of life. Genefic means high-quality research and development, innovation, and access that ultimately delivers better health outcomes.
The leadership team at Genefic and Genefic Specialty Pharmacy is comprised of dedicated professionals with vast experience: accomplished scientists, university professors, board-certified surgeons, doctors, and other esteemed medical staff, whose primary focus is creating healthy environments and increasing quality of life and improving health outcomes for people around the wor
In the ever-evolving field of healthcare, one of the most promising and transformative trends is the move toward personalized care through advancements made in technology. Local pharmacies are now emerging as key players in this major shift. towards tailored, patient-centric healthcare. In this blog post, we will explore how technology and health advancements are revolutionizing healthcare at local pharmacies, making it more personalized than ever before.
1. Digital Health Records and EHR Integration
Local pharmacies are moving away from traditional paper-based records and embracing digital health records. Electronic Health Record (EHR) systems are becoming more prevalent, allowing pharmacists to access a patient’s medical history quickly and easily. This integration enables pharmacists to provide medication recommendations and advice tailored to each patient’s unique health profile, reducing the risk of adverse drug interactions and ensuring medication adherence.
2. Medication Adherence Apps
Mobile applications are changing the game when it comes to medication adherence. Many local pharmacies now offer personalized apps that remind patients to take their medications on time, provide information about potential side effects, and offer convenient prescription refills. These apps empower patients to take control of their health while receiving guidance from their pharmacists.
3. Pharmacogenomics
Advancements in pharmacogenomics are enabling pharmacists to customize medication regimens based on a patient’s unique genetic makeup. By analyzing an individual’s genetic profile, pharmacists can identify how their body metabolizes certain drugs and adjust prescriptions accordingly. This personalized approach minimizes trial and error by finding the most effective and safe medications for each patient.
4. Telehealth Services
Telehealth and “telepharmacy” services have gained immense popularity, especially in remote areas where access to healthcare is limited. Through video consultations and virtual pharmacies, patients can consult with pharmacists from the comfort of their homes, receiving personalized advice and prescription recommendations without the need for a physical visit.
5. Medication Synchronization Programs
Local pharmacies are introducing medication synchronization programs, which allow patients to align all their prescription refills to a single, convenient date. Reducing the chances of missed doses simplifies medication management and improves overall patient satisfaction.
6. Health Monitoring Devices
Technological advancements have given rise to various health monitoring devices, such as wearable fitness trackers and smart scales. Local pharmacies are incorporating these tools into their personalized healthcare offerings as well. Pharmacists can monitor and analyze patients’ health data, guiding how to make lifestyle changes that promote better health outcomes.
7. Preventive Services
Beyond medication management, local pharmacies are expanding their services to include preventive healthcare. From offering vaccinations to conducting health screenings, pharmacies are quickly becoming holistic healthcare hubs focusing on keeping patients healthy and informed.
Conclusion
As technology and health advancements continue to evolve, local pharmacies are emerging as vital hubs for providing personalized healthcare services to their communities. This transformation enhances patient outcomes and strengthens the pharmacist-patient relationship, ensuring that each individual receives the care and attention they deserve.
Personalized healthcare is no longer a distant dream; it’s a reality that is unfolding in local pharmacies worldwide. Through integrating technology, implementing health advancements, and committing to patient-centric care, local pharmacies are becoming beacons of personalized healthcare, empowering individuals to take charge of their well-being like never before.
Pharmacies’ Roles in Dispensing Specialty Drugs
Over the past decade, more pharmaceuticals have been classified as specialty drugs.15 Specialty drugs are very expensive drugs, with a course of treatment in 2015 averaging $52,486.16 In 2019, only 4.9 percent of commercially insured patients took specialty drugs, but they were responsible for half of the total drug spend.17 Specialty drugs are also often complex biologic products, which may require special storage and additional training for pharmacists.
In response to the growth in specialty drugs, a niche type of pharmacy known as a specialty pharmacy has emerged. In 2018, 900 pharmacies in the U.S. had specialty accreditation.18 Specialty pharmacies operate separately from most retail pharmacies and are primarily owned and operated by PBMs, wholesalers, providers, or integrated delivery networks, though there are still some independent and small regional specialty pharmacies. Use of specialty pharmacies has been associated with higher rates of adherence than use of retail pharmacies for specialty drugs.
The large chain pharmacies such as CVS and Walgreens have been able to diversify to own both specialty and retail pharmacies, enabling them to create new integrated models aimed at improving medication adherence and other measures of clinical performance. For example, while most specialty pharmacies ship the drugs to patients, CVS’s “specialty at retail” model allows patients to access specialty drug patient management programs while picking up their specialty and traditional drugs at one location.19
Though quality is frequently used as a rationale for involving specialty pharmacies, it is difficult to determine the extent to which quality differs between specialty pharmacies and traditional retail pharmacies. Specialty pharmacies also may exacerbate drug spending if their prices are higher than those at retail pharmacies. There is little evidence on the extent of price competition within the specialty pharmacy sector and between specialty pharmacies, retail chain pharmacies, and independents. With specialty drugs driving growth in pharmaceutical spending, it will become increasingly important to ensure that as specialty drugs go off patent, the pharmacies selling them operate in a competitive environment that delivers the best quality at the lowest cost. More research will be needed to understand the impact that different pharmacy channels have on the cost and outcomes of these medications.
If DFCO pops it will poop afterward...
There are no fundamentals here. No unique IP or patents in any of their so-called divisions...
The rest of the story on "DepTec"
It was acquired from BONAR and his family. I'm sure they will use DFCO funds to build up the business and pay themselves wages, then when the stock goes bust they will repo the busiess.
Year Ended Jun 2023
Total Assets £783.29k
-£127.29k (-13.98%)
vs previous year
Total Liabilities
£-686.36k
-£128.6k (-23.06%)
vs previous year
Net Assets
£96.93k
-£255.89k (-72.53%)
vs previous year
Cash in Bank
£29.65k
-£152.42k (-83.72%)
vs previous year
Employees
8
+1 (+14.29%)
vs previous year
Turnover
Unreported
Debt Ratio (%)
87.63%
+26.38 (+43.07%)
vs previous year
Daily trading stats say this post is nonsense:
some action today compared to the past couple weeks!!!!
05/13/24 0.197 0.197 0.186 0.1959 26.959
05/10/24 0.1899 0.197 0.1899 0.197 6,189
05/09/24 0.197 0.197 0.19 0.19 30,328
05/08/24 0.186 0.19 0.186 0.19 6,120
05/07/24 0.181 0.19 0.181 0.19 1,178
05/06/24 0.1906 0.1906 0.1846 0.1846 10,240
05/03/24 0.1945 0.1962 0.185 0.185 26,204
05/02/24 0.196 0.1965 0.189 0.195 12,916
05/01/24 0.1928 0.1997 0.1928 0.1997 7,113
04/30/24 0.188 0.20 0.188 0.1969 53,295
04/29/24 0.19 0.20 0.188 0.1922 71,491
04/26/24 0.1972 0.1972 0.1853 0.188 170,059
04/25/24 0.209 0.209 0.192 0.1965 67,591
04/24/24 0.209 0.209 0.202 0.2089 45,395
04/23/24 0.2248 0.2262 0.19 0.19 168,402
04/22/24 0.235 0.235 0.225 0.2256 92,837
04/19/24 0.235 0.235 0.225 0.23 48,663
04/18/24 0.235 0.235 0.222 0.2325 25,145
04/17/24 0.235 0.235 0.221 0.2298 45,839
04/16/24 0.2257 0.235 0.2201 0.228 41,313
04/15/24 0.22 0.23 0.20 0.23 105,216
04/12/24 0.195 0.234 0.195 0.224 109,015
04/11/24 0.24 0.24 0.1902 0.2095 409,137
04/10/24 0.20 0.234 0.20 0.225 164,323
04/09/24 0.20 0.219 0.185 0.2114 105,197
04/08/24 0.16 0.22 0.16 0.20 466,217
04/05/24 0.165 0.165 0.152 0.1565 106,965
04/04/24 0.155 0.1697 0.1538 0.1665 218,343
04/03/24 0.1599 0.1599 0.15 0.1549 289,496
04/02/24 0.15 0.1599 0.15 0.1583 59,501
04/01/24 0.1519 0.154 0.143 0.1528 53,091
DFCO has never been headed anywhere other than BONAR's special place in purgatory,
Tell me about it...
I have been poisoned twice by flouroquinolones, the second time was in 2018. After being prescribed Cipro for a routine UTI I informed the Doc that I had already had an adverse reaction that took years to recover from....
... the asshat told me I would get "antibiotic resistance" if I didn't continue to take Cipro .
I recently found out that there were HUGE FDA WARNINGS in 2016.
So he is still treating (???? poisoning ????) patients while every day I deal with damaged mitochondria that steal my health and ability to function.
Most folks don't have a clue about market corruption...
It goes way beyond the influence of any CEO.......
Hedge funds and Market makers have been throwing their weight around for decades....
BUT NOW...
AI has amplified the ability of the "connected" persons and entities to manipulate.
The real value of a stock or it's IP has become totally irrelevant to stock price.
You don't have a clue about market corruption...
It goes way beyond the influence of any CEO.......
Hedge funds and Market makers have been throwing their weight around for decades....
BUT NOW...
AI has amplified the ability of the "connected" persons and entities to manipulate.
The real value of a stock or it's IP has become totally irrelevant to stock price.
ALGOS RULE!!!!!!
.... and anyone who believes in an "efficient market" is a damn fool.
LIDR has traded over 101 million shares this AM ?????
Really ?????
KEY STOCK DATA
P/E Ratio (TTM)
N/A
EPS (TTM)
$-14.71
Market Cap
$7.80 M
Shares Outstanding
6.50 M
Public Float
5.88 M
Yield
LIDR is not currently paying a regular dividend.
Latest Dividend
N/A
Ex-Dividend Date
N/A
?
SHORT INTEREST (04/30/24)
Shares Sold Short
212,756
Change from Last
-38.42%
Percent of Float
3.62%
This market is insane...LIDR
TING
NewsAEye Inc.
No significant news for in the past two years.
?
KEY STOCK DATA
P/E Ratio (TTM)
N/A
EPS (TTM)
$-14.71
Market Cap
$7.80 M
Shares Outstanding
6.50 M
Public Float
5.88 M
https://www.wsj.com/market-data/quotes/LIDR
05/10/24 1.48 2.54 1.46 2.20 volume at 93million at 9:38 am
05/06/24 1.17 1.26 1.1501 1.2303 55,110
05/03/24 1.06 1.18 1.06 1.14 110,230
05/02/24 1.00 1.11 0.986 1.03 102,421
05/01/24 1.01 1.0598 0.987 0.993 49,865
04/30/24 1.03 1.055 0.9873 1.02 42,073
04/29/24 1.00 1.03 0.9755 1.01 53,057
04/26/24 0.98 1.03 0.98 0.9902 43,650
04/25/24 0.9658 1.02 0.96 0.995 51,302
04/24/24 1.04 1.11 0.9537 0.9957 133,150
04/23/24 0.974 1.10 0.9504 1.06 150,152
04/22/24 1.04 1.04 0.9205 0.97 63,453
04/19/24 1.02 1.04 0.9801 1.00 37,678
04/18/24 1.04 1.05 1.02 1.02 44,470
04/17/24 1.00 1.07 1.00 1.03 55,554
04/16/24 1.08 1.08 0.9737 1.01 119,546
04/15/24 1.14 1.18 1.01 1.04 113,345
04/12/24 1.23 1.23 1.12 1.12 56,027
04/11/24 1.25 1.25 1.17 1.20 73,761
04/10/24 1.24 1.26 1.17 1.20 60,567
04/09/24 1.28 1.29 1.23 1.27 32,794
04/08/24 1.28 1.2899 1.21 1.27 56,184
Hmmm...
The replied to post is a link...
https://www.bloomberg.com/news/articles/2024-04-25/micron-clinches-total-of-up-to-13-6-billion-in-us-grants-loans
And this...
https://seekingalpha.com/article/4680240-micron-will-experience-strong-tailwinds-as-gpu-capacity-loosens-up
https://www.micron.com/products/memory/cxl-memory?gad_source=1&gclid=Cj0KCQjwxeyxBhC7ARIsAC7dS39tiBTvWHLLm5bwJTm8W3g6mSFah-80xcz3JgvrKeSx77QJtVvtRPQaAm2vEALw_wcB
https://www.bloomberg.com/news/articles/2024-04-25/micron-clinches-total-of-up-to-13-6-billion-in-us-grants-loans
And this...
https://patents.justia.com/inventor/cory-pecinovsky
Yes, this may be a pump piece...
But many of the points they are discussing are real. Quants rule in the 21st Century.
https://secure.tradesmith.com/?cid=MKT794412&eid=MKT799581&tid=aa7736fc7a0e4512945933c1cf198e90&assetId=AST337263&page=2
I'm sure Brian Bonar agress with you 100% batty boots...
But with your track record and Bonar's we know it's 100% B.S.
Bonar has been ripping off ignorant stockholders for almost 50 years !!!!!!!
Sounds like B.S. to me.... PHA LLC has no I.P.
https://jiwuliproducts.com/
I believe that it is possible... maybe even probable... that every share traded today was AI controlled wash trading.
The manipulators can run their algos up and down the hill with out penalty.
You mean more unaudited B.S. from BONAR?
DALRADA FINANCIAL CORPORATION.
Table of Contents
PART I – FINANCIAL INFORMATION 3
Item 1. Unaudited Interim Condensed Consolidated Financial Statements 3
Unaudited Interim Condensed Consolidated Balance Sheets 3
Unaudited Interim Condensed Consolidated Statements of Operations and Comprehensive Loss 4
Unaudited Interim Condensed Consolidated Statements of Stockholders’ Equity (Deficit) 5
Unaudited Interim Condensed Consolidated Statements of Cash Flows 7
Notes to the Unaudited Interim Condensed Consolidated Financial Statements 8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 35
Item 3. Quantitative and Qualitative Disclosures About Market Risk 42
Item 4. Controls and Procedures 42
PART II – OTHER INFORMATION 43
Item 1. Legal Proceedings 43
Item 1A. Risk Factors 43
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds Securities 43
Item 3. Defaults Upon Senior Securities 43
Item 4. Mine Safety Disclosures 43
Item 5. Other Information 43
Item 6. Exhibits 44
SIGNATURES 45
Um... It is possible to correct an error in a post when you see it right away.
DUH !!!!!!
From Google AI:
Many companies make heat pumps for homes in the United States, including:
Carrier Corporation
A Florida-based company that manufactures heating, ventilation, and air conditioning systems. In 2023, Carrier released a new heat pump series that meets the Department of Energy's minimum efficiency requirements.
Daikin
A Japanese multinational that offers a variety of heat pumps for residential and commercial use. Daikin has a strong presence in the heat pump market and is known for its reliable and efficient products.
Rheem
An Atlanta, Georgia-based company that manufactures in Arkansas, Alabama, California, and Minnesota. All of Rheem's manufacturing facilities are ISO 9001 certified.
Trane
A company that manufactures heat pumps and central air conditioners in Arkansas, Florida, Georgia, Missouri, New Jersey, and Texas. Trane and American Standard are sister companies that share a manufacturing facility in Tyler, Texas.